{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:43Z","timestamp":1794028303419,"version":"4.8.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"7","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Four variants have been continuously subjected to debate and received different von Willebrand disease (VWD) classifications: p.R1315L, p.R1315C, p.R1374H, and p.R1374C. We chose to comprehensively investigate these variants with full set of VWD tests, protein-modeling predictions and applying structural biology. Patients with p.R1315L, p.R1315C, p.R1374H, and p.R1374C were included. A group with type 2A and 2M was included to better understand similarities and differences. Patients were investigated for phenotypic assays and underlying disease mechanisms. We applied deep protein modeling predictions and structural biology to elucidate the causative effects of variants. Forty-three patients with these variants and 70 with 2A (n\u00a0= 35) or 2M (n\u00a0= 35) were studied. Patients with p.R1315L, p.R1374H, or p.R1374C showed a common phenotype between 2M and 2A using von Willebrand factor (VWF):GPIbR\/VWF:Ag and VWF:CB\/VWF:Ag ratios and VWF multimeric profile, whereas p.R1315C represented a type 2M phenotype. There was an overall reduced VWF synthesis or secretion in 2M and cases with p.R1315L, p.R1374H, and p.R1374C, but not in 2A. Reduced VWF survival was observed in most 2A (77%), 2M (80%), and all 40 cases with p.R1315L, p.R1374H, and p.R1374C. These were the only variants that fall at the interface between the A1-A2 domains. p.R1315L\/C mutants induce more compactness and internal mobility, whereas p.R1374H\/C display a more extended overall geometry. We propose a new classification of type 2M\/2A for p.R1315L, p.R1374H, and p.R1374C because they share a common phenotype with 2M and 2A. Our structural analysis shows the unique location of these variants on the A1-A2 domains and their distinctive effect on VWF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012626","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:14:52Z","timestamp":1707146092000},"page":"1725-1736","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Type 2M\/2A von Willebrand disease: a shared phenotype between type 2M and 2A"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-7879","authenticated-orcid":false,"given":"Omid","family":"Seidizadeh","sequence":"first","affiliation":[{"name":"1Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mollica","sequence":"additional","affiliation":[{"name":"2Department of Medical Biotechnologies and Translational Medicine, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Zambarbieri","sequence":"additional","affiliation":[{"name":"2Department of Medical Biotechnologies and Translational Medicine, Universit\u00e0 degli Studi di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-6011","authenticated-orcid":false,"given":"Paola","family":"Colpani","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-3773","authenticated-orcid":false,"given":"Giovanna","family":"Cozzi","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-2271","authenticated-orcid":false,"given":"Maria Teresa","family":"Pagliari","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ciavarella","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-7519","authenticated-orcid":false,"given":"Simona M.","family":"Siboni","sequence":"additional","affiliation":[{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[{"name":"1Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"},{"name":"3Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"issue":"2","key":"2024040516411789400_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"2024040516411789400_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"2024040516411789400_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"2024040516411789400_bib4","first-page":"743","author":"Bloom","year":"1991"},{"issue":"1","key":"2024040516411789400_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases","volume":"8","author":"Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"},{"issue":"10","key":"2024040516411789400_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"1","key":"2024040516411789400_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"13","key":"2024040516411789400_bib8","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"2024040516411789400_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"4","key":"2024040516411789400_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood"},{"issue":"20","key":"2024040516411789400_bib11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2024040516411789400_bib12","first-page":"77","article-title":"A\u00a0sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"2024040516411789400_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/rth2.12141","article-title":"Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers","volume":"2","author":"Bowyer","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"2024040516411789400_bib14","doi-asserted-by":"publisher","DOI":"10.1055\/a-2186-6362","article-title":"Clinical and laboratory presentation and underlying mechanism in patients with low VWF","author":"Seidizadeh","year":"2  2023","journal-title":"Thromb Haemostasis"},{"issue":"5","key":"2024040516411789400_bib15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","volume":"21","author":"Seidizadeh","year":"2023","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"4","key":"2024040516411789400_bib16","first-page":"536","article-title":"Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease","volume":"84","author":"Baronciani","year":"2000","journal-title":"Thromb Haemostasis"},{"issue":"3","key":"2024040516411789400_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"issue":"15","key":"2024040516411789400_bib18","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/bloodadvances.2020003397","article-title":"Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"5","author":"Baronciani","year":"2021","journal-title":"Blood Adv"},{"key":"2024040516411789400_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2021.06.030","article-title":"High-resolution structure of the vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine for treating acquired TTP","volume":"567","author":"Lee","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"2024040516411789400_bib20","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7873","key":"2024040516411789400_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"11","key":"2024040516411789400_bib22","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/ct200563j","article-title":"Parallel generalized Born implicit solvent calculations with NAMD","volume":"7","author":"Tanner","year":"2011","journal-title":"J\u00a0Chem Theor Comput"},{"issue":"4","key":"2024040516411789400_bib23","first-page":"044130","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J\u00a0Chem Phys"},{"issue":"2","key":"2024040516411789400_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J\u00a0Comput Chem"},{"key":"2024040516411789400_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"8","key":"2024040516411789400_bib26","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"issue":"2","key":"2024040516411789400_bib27","first-page":"926","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J\u00a0Chem Phys"},{"issue":"3","key":"2024040516411789400_bib28","first-page":"3525","article-title":"Energy minimization and conformation analysis of molecules using steepest descent method","volume":"5","author":"Jaidhan","year":"2014","journal-title":"Int J Comput Sci Inf Technol"},{"issue":"12","key":"2024040516411789400_bib29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J\u00a0Comput Chem"},{"issue":"1","key":"2024040516411789400_bib30","first-page":"33-28","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J\u00a0Mol Graph"},{"issue":"15","key":"2024040516411789400_bib31","doi-asserted-by":"crossref","first-page":"e2116790119","DOI":"10.1073\/pnas.2116790119","article-title":"Helical self-assembly of a mucin segment suggests an evolutionary origin for von Willebrand factor tubules","volume":"119","author":"Javitt","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2024040516411789400_bib32","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"Borr\u00e0s","year":"2017","journal-title":"Haematologica"},{"issue":"11","key":"2024040516411789400_bib33","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A\u00a0laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"2024040516411789400_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemostasis"},{"issue":"6","key":"2024040516411789400_bib35","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1097\/HS9.0000000000000718","article-title":"Importance of genotyping in von Willebrand disease to elucidate pathogenic mechanisms and variability in phenotype","volume":"6","author":"Atiq","year":"2022","journal-title":"HemaSphere"},{"issue":"1","key":"2024040516411789400_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jth.15129","article-title":"Laboratory variability in the diagnosis of type 2 VWD variants","volume":"19","author":"DiGiandomenico","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"1","key":"2024040516411789400_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1160\/TH12-07-0475","article-title":"Characterisation of mutations and molecular studies of type 2 von Willebrand disease","volume":"109","author":"Ahmad","year":"2013","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"2024040516411789400_bib38","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1111\/hae.13714","article-title":"Genetic variants of VWF gene in type 2 von Willebrand disease","volume":"25","author":"Freitas","year":"2019","journal-title":"Haemophilia"},{"key":"2024040516411789400_bib39","first-page":"483","author":"Favaloro","year":"2016"},{"issue":"5","key":"2024040516411789400_bib40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.bpj.2014.07.026","article-title":"Misfolding of vWF to pathologically disordered conformations impacts the severity of von Willebrand disease","volume":"107","author":"Tischer","year":"2014","journal-title":"Biophys J"},{"issue":"1","key":"2024040516411789400_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02981973","article-title":"Molecular genetics of type 2 von Willebrand disease","volume":"75","author":"Fressinaud","year":"2002","journal-title":"Int J Hematol"},{"issue":"8","key":"2024040516411789400_bib42","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.13742","article-title":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","volume":"15","author":"Doruelo","year":"2017","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"3","key":"2024040516411789400_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20470","article-title":"von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)","volume":"80","author":"Penas","year":"2005","journal-title":"Am J Hematol"},{"issue":"1","key":"2024040516411789400_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","article-title":"Genetic testing for von Willebrand disease: the case against","volume":"8","author":"Favaloro","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"2-3","key":"2024040516411789400_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000214853","article-title":"Laboratory diagnosis of von Willebrand disease type 1\/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1\u2013B3 and C1\u2013C2 domains of the von Willebrand factor gene: role of von Willebrand factor multimers and the von Willebrand factor propeptide\/antigen ratio","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol"},{"issue":"299","key":"2024040516411789400_bib46","first-page":"2","article-title":"Determination of two rapid von Willebrand factor (VWF) activity assays VWF: Gpibm and VWF: Gpibr in well defined von Willebrand disease patients using a complete set of classical and sensitive VWF assays","volume":"6","author":"Michiels","year":"2019","journal-title":"J Hematol Thrombo Dis"},{"issue":"9","key":"2024040516411789400_bib47","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1074\/jbc.M113.511220","article-title":"Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib","volume":"289","author":"Blenner","year":"2014","journal-title":"J\u00a0Biol Chem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/7\/1725\/2220710\/blooda_adv-2024-012626-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/7\/1725\/2220710\/blooda_adv-2024-012626-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T12:41:39Z","timestamp":1712320899000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/7\/1725\/514817\/Type-2M-2A-von-Willebrand-disease-a-shared"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012626","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}